Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scheibenbogen

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|August 5, 2000
High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanomaA Letsch, U Keilholz, D Schadendorf, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 5, 2002
[Choroid melanoma. Adjuvant therapy in high risk patients and new therapy approaches in the metastatic stage]N E Bechrakis, C Scheibenbogen, A Schmittel, et al.
The Cancer Journal From Scientific American|February 11, 1998
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative GroupU Keilholz, G Stoter, C J Punt, et al.
Journal of Immunological Methods|January 11, 2001
Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteinsA Schmittel, U Keilholz, S Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastasesU Keilholz, C Scheibenbogen, M Brado, et al.
Immunobiology|September 1, 1991
Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta productionK Zwingenberger, G Harms, C Pedrosa, et al.
Leukemia|March 4, 2005
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targetsO Penack, C Gentilini, L Fischer, et al.
Cancer Research|September 15, 1995
A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral bloodP Brossart, J W Schmier, S Krüger, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1996
[Clinical significance of cytokines Il-6, Il-8 and C-reactive protein in serum of patients with acute pancreatitis]E Stoelben, M Nagel, D Ockert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapyM Willhauck, T Möhler, C Scheibenbogen, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|August 5, 2000
High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanomaA Letsch, U Keilholz, D Schadendorf, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 5, 2002
[Choroid melanoma. Adjuvant therapy in high risk patients and new therapy approaches in the metastatic stage]N E Bechrakis, C Scheibenbogen, A Schmittel, et al.
The Cancer Journal From Scientific American|February 11, 1998
Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative GroupU Keilholz, G Stoter, C J Punt, et al.
Journal of Immunological Methods|January 11, 2001
Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteinsA Schmittel, U Keilholz, S Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer (LAK) cells for liver metastasesU Keilholz, C Scheibenbogen, M Brado, et al.
Immunobiology|September 1, 1991
Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta productionK Zwingenberger, G Harms, C Pedrosa, et al.
Leukemia|March 4, 2005
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targetsO Penack, C Gentilini, L Fischer, et al.
Cancer Research|September 15, 1995
A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral bloodP Brossart, J W Schmier, S Krüger, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 1, 1996
[Clinical significance of cytokines Il-6, Il-8 and C-reactive protein in serum of patients with acute pancreatitis]E Stoelben, M Nagel, D Ockert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapyM Willhauck, T Möhler, C Scheibenbogen, et al.
Pageof 7